UNC Eshelman School of Pharmacy collaborates with UNC Health Care to improve, optimize patient care

October 29, 2019

Researchers at the UNC Eshelman School of Pharmacy’s Center for Medication Optimization, in collaboration with UNC Health Care’s Pharmacy Services team, are coming together to improve and optimize patient care delivery, pharmacy analytics and outcomes. The partnership, called Optimizing Care Delivery, is a unique collaboration between an academic research center and a health system in North Carolina. The goal of the program is to develop, test and evaluate clinical pharmacy services that facilitates proactive, coordinated and connected care, especially for patients who manage chronic conditions. Optimizing Care Delivery will allow pharmacists and physicians to work hand-in-hand to address unmet needs … Continued

Eshelman Institute for Innovation awards $3.5 million across 24 research projects

May 29, 2019

On June 1, the Eshelman Institute for Innovation (EII) awarded $3.5 million across 24 projects to support research and education at the UNC Eshelman School of Pharmacy. The EII, created in 2014 with a $100 million gift from alumnus and pharmaceutical executive, Fred Eshelman, serves as an engine for innovation within the UNC Eshelman School of Pharmacy. Continuing on the previous theme, in this cycle the Institute is funding innovative solutions to address society’s pressing problems in healthcare, such as developing therapeutics for cancer, utilizing 3D approaches to treat osteoporosis, developing artificial intelligence to predict adverse drug events, and implementing … Continued

Accelerate Brain Cancer Cure grants researchers $170,000

May 24, 2019

Goal to develop tumor-homing stem cell beacons for immune-based cancer therapy Shawn Hingtgen, Ph.D., Gianpietro Dotti, Ph.D., and Samir Mitragotri, Ph.D., had an idea – collaborate to create a cell therapy unlike any other to target hard-to-treat cancers. The three researchers from the UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, and Harvard University, are utilizing each of their strengths to develop a new approach to cell therapy for brain cancer. Hingtgen said their team is developing a hybrid cell therapy that begins by loading neural stem cells with nanoparticle “backpacks”. When released into the brain, the cells … Continued

Researchers study strategies for using nanotechnology to boost cancer therapeutics

May 2, 2019

University of North Carolina Lineberger Comprehensive Cancer Center researchers presented innovative new strategies for using tiny particles – particles the size of a DNA molecule or the width of a human hair – to boost cancer treatment as part of the Carolina Center of Cancer Nanotechnology Excellence/National Cancer Institute site visit on Tuesday. The researchers, who are members of the Carolina Center of Cancer Nanotechnology Excellence, delivered updates on their latest research into using nanotechnology to potentially improve cancer treatment as part of the day’s agenda of meetings, talks and poster presentations at the Carolina Club. “The Carolina Center for Cancer … Continued

UNC Study Reveals Precision Oncology Insights for Colorectal Cancer

March 25, 2019

Next-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to different survival and treatment outcomes in an analysis led by a researcher at the UNC Eshelman School of Pharmacy. The findings, published in the Journal of Clinical Oncology, could help define strategies to more effectively treat colorectal cancer, the second leading cause of cancer death in the United States. “This is an example of precision oncology, where using genetics, we are able to stratify tumor types that we once believed were homogeneous, and to identify new patient subgroups that might benefit from tailored therapies,” … Continued

Mucommune Receives Over $3M to Advance Muco-Trapping Antibodies

March 20, 2019

Mucommune LLC has been awarded over $3 million in five separate federal grants over the past several months to advance its muco-trapping antibody technology. The company was launched in 2016 by Sam Lai, Ph.D., an associate professor at the UNC Eshelman School of Pharmacy. The muco-trapping antibody technology advanced by Mucommune is based on engineering the Fc region of IgG antibodies to interact with mucins. Tuning the Fc region to combine with mucins enables antibodies to immobilize viral and bacterial pathogens in different mucosal secretions, including respiratory airways, GI tract and female reproductive tract. Once the pathogens are trapped in … Continued

Curtis Media Group’s Rick Martinez interviews CMO Director Jon Easter

January 29, 2019

Curtis Media Group’s Rick Martinez recently interviewed Center for Medication Optimization Director Jon Easter after the center’s recent Medication Optimization Summit in January at the Carolina Inn in Chapel Hill, NC.    

CMO Summit Takes On Medication Mismanagement

January 22, 2019

The UNC Eshelman School of Pharmacy and the School’s Center for Medication Optimization brought together leaders from across the health care industry to highlight the multi-billion dollar problem of medication mismanagement and develop collaborative medication optimization strategies that aim to transform health care. More than half of the U.S. population takes multiple medications daily to help treat one or more chronic conditions, such as hypertension and diabetes. Other serious conditions, like cancer and HIV, have extremely complex regimens that must be coordinated. And when these medication regimens are mismanaged by health care providers and patients, it can lead to unnecessary medical … Continued

Former Dean Robert Blouin’s Official Portrait Unveiled

December 3, 2018

Robert Blouin, Pharm.D., who for 14 years served as dean of the UNC Eshelman School of Pharmacy, was honored Nov. 30 with the unveiling of his official portrait. Blouin served as dean from 2003 to 2017. During his tenure, the School increased external research funding by over 800 percent, doubled the number of full-time faculty, founded the Eshelman Institute of Innovation and various new research centers, opened its Asheville satellite campus, and forged numerous research partnerships — all of which contributed to the School’s ascension to the top-ranked pharmacy school in the country. “Throughout his 14-year tenure as Dean of … Continued

Huang, Kabanov and Roth Recognized for Research Influence

November 28, 2018

Three faculty members from the UNC Eshelman School of Pharmacy were recognized on the Clarivate Analytics list of Highly Cited Researchers for 2018. Leaf Huang, Ph.D., Alexander Kabanov, Ph.D., Dr.Sci., and Bryan Roth, Ph.D., M.D., were among 6,000 scientists worldwide and across all fields who were recognized for their influence, through the publication of multiple highly cited papers, over the last decade. Huang, Kabanov and Roth were three of the 34 UNC-Chapel Hill scientists recognized. Huang is a Fred Eshelman Distinguished Professor, who joined the School’s faculty in 2005. He has published over 380 peer-reviewed articles, over 160 invited reviews … Continued